Fallah PN (2026). [PMID: 40399211](https://pubmed.ncbi.nlm.nih.gov/40399211/). *Int J Gynecol Cancer*. [Clinical Trial Publication]
Kroon KR (2026). [PMID: 41607005](https://pubmed.ncbi.nlm.nih.gov/41607005/). *Int J Cancer*. [Diagnostic / Biomarker]
Contreras Garduño S (2026). [PMID: 41384723](https://pubmed.ncbi.nlm.nih.gov/41384723/). *Cancer Epidemiol Biomarkers Prev*. [Basic Science / Preclinical]
Rothnie K (2026). [PMID: 42000375](https://pubmed.ncbi.nlm.nih.gov/42000375/). *Gynecol Oncol*. [Diagnostic / Biomarker]
Soltani LF (2026). [PMID: 41698781](https://pubmed.ncbi.nlm.nih.gov/41698781/). *J Am Board Fam Med*. [Diagnostic / Biomarker]
Li P (2026). [PMID: 41629932](https://pubmed.ncbi.nlm.nih.gov/41629932/). *BMC Womens Health*. [Diagnostic / Biomarker]
Chibwesha CJ (2026). [PMID: 41780745](https://pubmed.ncbi.nlm.nih.gov/41780745/). *Contemporary clinical trials*. [Epidemiology / Natural History]
Teodoro NS (2026). [PMID: 41891028](https://pubmed.ncbi.nlm.nih.gov/41891028/). *medRxiv*. [Clinical Trial Publication]
Tian X (2026). [PMID: 41638692](https://pubmed.ncbi.nlm.nih.gov/41638692/). *BMJ (Clinical research ed.)*. [Other]
Anton ET (2026). [PMID: 41682842](https://pubmed.ncbi.nlm.nih.gov/41682842/). *J Clin Med*. [Review / Meta-Analysis]
